Pre-analytical in-vitro stability of [-2]proPSA in blood and serum
Authors:
- Axel SemjonowASAxel Semjonow
- Thomas KöpkeTKThomas Köpke
- Elke EltzeEEElke Eltze
- Beate Pepping-SchefersBPBeate Pepping-Schefers
- Hilla BürgelHBHilla Bürgel
- Claude DarteCDClaude Darte
- 1 July 2010
- journal article
- research article
- Published by Elsevier in Clinical Biochemistry
- Vol. 43 (10-11) , 926-928
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Short‐term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’ studyBJU International, 2010
- A [‐2]proPSA‐based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseasesThe Prostate, 2008
- [-2]Proenzyme Prostate Specific Antigen for Prostate Cancer Detection: A National Cancer Institute Early Detection Research Network Validation StudyJournal of Urology, 2008
- A MULTICENTER CLINICAL TRIAL ON THE USE OF (–5, –7) PRO PROSTATE SPECIFIC ANTIGENJournal of Urology, 2005
- Evaluation of precursor prostate-specific antigen isoform ratios in the detection of prostate cancerUrologic Oncology: Seminars and Original Investigations, 2005
- Proenzyme Forms of Prostate-Specific Antigen in Serum Improve the Detection of Prostate CancerClinical Chemistry, 2004
- Serum Pro Prostate Specific Antigen Improves Cancer Detection Compared to Free and Complexed Prostate Specific Antigen in Men With Prostate Specific Antigen 2 to 4 Ng/MlJournal of Urology, 2003
- Activation of the Zymogen Form of Prostate-Specific Antigen by Human Glandular Kallikrein 2Biochemical and Biophysical Research Communications, 1997
- Characterization of the Precursor of Prostate-specific AntigenJournal of Biological Chemistry, 1997
- Molecular cloning of human prostate specific antigen cDNAFEBS Letters, 1987